Cardiomyopathy pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
(One intermediate revision by the same user not shown)
Line 3: Line 3:
{{CMG}}
{{CMG}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Different causes of cardiomyopathies , including genetic and acquired causes, result in abnormal heart structure and function. As the function of the heart deteriorates, symptoms of heart failure become apparent. On the other hand, defects in ion channels and hypertrophic cardiomyopathy can be present with fatal arrhythmias and sudden cardiac death without the preceding symptoms of heart failure.
 
*In DCM the heart (especially the [[left ventricle]]) is enlarged and the pumping function is diminished. Approximately 40% of cases are familial, but the [[genetics]]<nowiki/>are poorly understood compared with HCM. In some cases it manifests as [[peripartum cardiomyopathy]], and in other cases it may be associated with alcoholism.
*[[Hypertrophic cardiomyopathy]](HCM or HOCM), a [[genetic disorder]]<nowiki/>caused by various [[mutation]]s<nowiki/>in genes encoding [[Sarcomere|sarcomeric]]<nowiki/>proteins. In HCM the heart muscle is thickened, which can obstruct blood flow and prevent the heart from functioning properly.
*[[Arrhythmogenic right ventricular cardiomyopathy]](ARVC) arises from an electrical disturbance of the heart in which heart muscle is replaced by fibrous scar tissue. The [[right ventricle]]<nowiki/>is generally most affected.
*[[Restrictive cardiomyopathy]](RCM) is an uncommon cardiomyopathy. The walls of the ventricles are stiff, but may not be thickened, and resist the normal filling of the heart with blood. A rare form of restrictive cardiomyopathy is the obliterative cardiomyopathy, seen in the [[hypereosinophilic syndrome]]. In this type of cardiomyopathy, the myocardium in the apices of the left and right ventricles becomes thickened and fibrotic, causing a decrease in the volumes of the ventricles and a type of restrictive cardiomyopathy.
*[[Noncompaction cardiomyopathy]]<nowiki/>has been recognized as a separate type since the 1980s. The term refers to a cardiomyopathy where the left ventricle wall has failed to grow properly from birth and has a spongy appearance when viewed during an echocardiogram. These patients are at risk of heart failure, thromboembolic phenomena and sudden cardiac death.
==Pathophysiology==
==Pathophysiology==


Line 15: Line 21:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 23: Line 28:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 38: Line 42:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 46: Line 49:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 54: Line 56:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 69: Line 70:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 77: Line 77:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 85: Line 84:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 93: Line 91:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 101: Line 98:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 118: Line 114:
</gallery>
</gallery>
</div>
</div>


<div align="left">
<div align="left">
Line 129: Line 124:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
# Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 05:16, 16 December 2018

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy pathophysiology

CDC on Cardiomyopathy pathophysiology

Cardiomyopathy pathophysiology in the news

Blogs on Cardiomyopathy pathophysiology

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Different causes of cardiomyopathies , including genetic and acquired causes, result in abnormal heart structure and function. As the function of the heart deteriorates, symptoms of heart failure become apparent. On the other hand, defects in ion channels and hypertrophic cardiomyopathy can be present with fatal arrhythmias and sudden cardiac death without the preceding symptoms of heart failure.

  • In DCM the heart (especially the left ventricle) is enlarged and the pumping function is diminished. Approximately 40% of cases are familial, but the geneticsare poorly understood compared with HCM. In some cases it manifests as peripartum cardiomyopathy, and in other cases it may be associated with alcoholism.
  • Hypertrophic cardiomyopathy(HCM or HOCM), a genetic disordercaused by various mutationsin genes encoding sarcomericproteins. In HCM the heart muscle is thickened, which can obstruct blood flow and prevent the heart from functioning properly.
  • Arrhythmogenic right ventricular cardiomyopathy(ARVC) arises from an electrical disturbance of the heart in which heart muscle is replaced by fibrous scar tissue. The right ventricleis generally most affected.
  • Restrictive cardiomyopathy(RCM) is an uncommon cardiomyopathy. The walls of the ventricles are stiff, but may not be thickened, and resist the normal filling of the heart with blood. A rare form of restrictive cardiomyopathy is the obliterative cardiomyopathy, seen in the hypereosinophilic syndrome. In this type of cardiomyopathy, the myocardium in the apices of the left and right ventricles becomes thickened and fibrotic, causing a decrease in the volumes of the ventricles and a type of restrictive cardiomyopathy.
  • Noncompaction cardiomyopathyhas been recognized as a separate type since the 1980s. The term refers to a cardiomyopathy where the left ventricle wall has failed to grow properly from birth and has a spongy appearance when viewed during an echocardiogram. These patients are at risk of heart failure, thromboembolic phenomena and sudden cardiac death.

Pathophysiology

Gross Pathology

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Microscopic Pathology

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

References

  1. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.

Template:WH Template:WS